BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 30844974)

  • 1. Prognostic Impact of Tumor-Infiltrating Lymphocytes in Primary and Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis.
    Kong JC; Guerra GR; Pham T; Mitchell C; Lynch AC; Warrier SK; Ramsay RG; Heriot AG
    Dis Colon Rectum; 2019 Apr; 62(4):498-508. PubMed ID: 30844974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of tumor-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: a systematic review and meta-analysis.
    Zhao Y; Ge X; He J; Cheng Y; Wang Z; Wang J; Sun L
    World J Surg Oncol; 2019 May; 17(1):85. PubMed ID: 31118034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Implications of Tumor Infiltrating Lymphocytes in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Idos GE; Kwok J; Bonthala N; Kysh L; Gruber SB; Qu C
    Sci Rep; 2020 Feb; 10(1):3360. PubMed ID: 32099066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Density of tumor-infiltrating FOXP3+ T cells as a response marker for induction chemoradiotherapy and a potential prognostic factor in patients treated with trimodality therapy for locally advanced non-small cell lung cancer.
    Tao H; Shien K; Soh J; Matsuda E; Toyooka S; Okabe K; Miyoshi S
    Ann Thorac Cardiovasc Surg; 2014; 20(6):980-6. PubMed ID: 24583705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of CD8+ tumor-infiltrating lymphocytes in stage III colorectal cancer with and without microsatellite instability.
    Prall F; Dührkop T; Weirich V; Ostwald C; Lenz P; Nizze H; Barten M
    Hum Pathol; 2004 Jul; 35(7):808-16. PubMed ID: 15257543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prognostic Significance of the Tumor-infiltrating Programmed Cell Death-1
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Nakao S; Matsutani S; Hirakawa K; Ohira M
    Anticancer Res; 2017 Aug; 37(8):4165-4172. PubMed ID: 28739701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer.
    Salama P; Phillips M; Grieu F; Morris M; Zeps N; Joseph D; Platell C; Iacopetta B
    J Clin Oncol; 2009 Jan; 27(2):186-92. PubMed ID: 19064967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of CD45RO(+) tumor-infiltrating lymphocytes for locally advanced rectal cancer following 30 Gy/10f neoadjuvant radiotherapy.
    Wang L; Zhai ZW; Ji DB; Li ZW; Gu J
    Int J Colorectal Dis; 2015 Jun; 30(6):753-60. PubMed ID: 25935450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite: A cohort study.
    Berntsson J; Svensson MC; Leandersson K; Nodin B; Micke P; Larsson AH; Eberhard J; Jirström K
    Int J Cancer; 2017 Oct; 141(8):1654-1666. PubMed ID: 28677162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis.
    Mei Z; Liu Y; Liu C; Cui A; Liang Z; Wang G; Peng H; Cui L; Li C
    Br J Cancer; 2014 Mar; 110(6):1595-605. PubMed ID: 24504370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of tumor-infiltrating lymphocytes for patients with colorectal cancer.
    Huh JW; Lee JH; Kim HR
    Arch Surg; 2012 Apr; 147(4):366-72. PubMed ID: 22508783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of neoadjuvant chemoradiation on tumor-infiltrating/associated lymphocytes in locally advanced rectal cancers.
    Lim SH; Chua W; Cheng C; Descallar J; Ng W; Solomon M; Bokey L; Wong K; Lee MT; de Souza P; Shin JS; Lee CS
    Anticancer Res; 2014 Nov; 34(11):6505-13. PubMed ID: 25368252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.
    Schweiger T; Berghoff AS; Glogner C; Glueck O; Rajky O; Traxler D; Birner P; Preusser M; Klepetko W; Hoetzenecker K
    Clin Exp Metastasis; 2016 Oct; 33(7):727-39. PubMed ID: 27449756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of epithelial-mesenchymal transition driver brachyury and status of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in predicting treatment responses to neoadjuvant chemotherapy of breast cancer.
    Lee KH; Kim EY; Park YL; Do SI; Chae SW; Park CH
    Tumour Biol; 2017 Jun; 39(6):1010428317710575. PubMed ID: 28621227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer.
    Shinto E; Hase K; Hashiguchi Y; Sekizawa A; Ueno H; Shikina A; Kajiwara Y; Kobayashi H; Ishiguro M; Yamamoto J
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S414-21. PubMed ID: 24566864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-infiltrating lymphocytes in breast cancer predict the response to chemotherapy and survival outcome: A meta-analysis.
    Wang K; Xu J; Zhang T; Xue D
    Oncotarget; 2016 Jul; 7(28):44288-44298. PubMed ID: 27329588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kashiwagi S; Tanaka H; Hirakawa K; Ohira M
    BMC Cancer; 2018 Apr; 18(1):371. PubMed ID: 29614981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD3+ cells at the invasive margin of deeply invading (pT3-T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study.
    Laghi L; Bianchi P; Miranda E; Balladore E; Pacetti V; Grizzi F; Allavena P; Torri V; Repici A; Santoro A; Mantovani A; Roncalli M; Malesci A
    Lancet Oncol; 2009 Sep; 10(9):877-84. PubMed ID: 19656725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image analyzer-based assessment of tumor-infiltrating T cell subsets and their prognostic values in colorectal carcinomas.
    Kim Y; Bae JM; Li G; Cho NY; Kang GH
    PLoS One; 2015; 10(4):e0122183. PubMed ID: 25875774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response in colorectal carcinoma: a review of its significance as a predictive and prognostic biomarker.
    Bell PD; Pai RK
    Histopathology; 2022 Dec; 81(6):696-714. PubMed ID: 35758208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.